Q1 2025 · 13F-HR
RA CAPITAL MANAGEMENT, L.P.holdings as filed
Filed 2025-05-15 · accession 0001104659-25-049549
$5.99B
Reported value
85
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S - ADR | $1.60B | 26.8% | 10,281,496 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $460.3M | 7.69% | 12,189,149 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $322.3M | 5.38% | 6,084,412 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $302.1M | 5.05% | 11,189,693 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA CO NV | $207.5M | 3.47% | 10,138,938 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $199.2M | 3.33% | 3,036,527 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $196.0M | 3.27% | 8,909,091 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $186.0M | 3.11% | 6,300,408 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $147.1M | 2.46% | 18,202,009 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $144.6M | 2.41% | 19,889,683 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $136.6M | 2.28% | 10,860,977 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $109.3M | 1.82% | 10,445,322 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $107.4M | 1.79% | 4,178,823 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $101.6M | 1.70% | 9,714,392 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $98.9M | 1.65% | 10,637,290 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $97.6M | 1.63% | 6,147,280 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $96.0M | 1.60% | 60,379,366 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $94.5M | 1.58% | 3,743,018 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $90.6M | 1.51% | 6,955,993 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $78.3M | 1.31% | 1,577,106 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $76.6M | 1.28% | 6,944,648 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $58.6M | 0.98% | 1,569,491 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $52.0M | 0.87% | 2,866,733 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD-ADR | $46.8M | 0.78% | 1,295,040 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $45.6M | 0.76% | 5,755,577 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $40.5M | 0.68% | 6,995,858 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $38.6M | 0.64% | 2,538,925 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $38.3M | 0.64% | 31,419,267 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HOLDING CORP | $36.5M | 0.61% | 1,136,453 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $35.5M | 0.59% | 3,206,271 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $29.6M | 0.49% | 9,853,302 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $29.5M | 0.49% | 10,229,099 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $28.4M | 0.48% | 39,646,039 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $27.3M | 0.46% | 5,105,213 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $26.4M | 0.44% | 4,004,610 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $26.3M | 0.44% | 1,517,418 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $23.5M | 0.39% | 1,092,796 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $23.1M | 0.39% | 9,192,092 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $22.1M | 0.37% | 1,347,252 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $21.8M | 0.36% | 3,649,057 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $20.6M | 0.34% | 1,150,000 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $19.9M | 0.33% | 10,805,129 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $18.7M | 0.31% | 190,256 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $18.6M | 0.31% | 511,207 | Common | SOLE |
| 59267L107 | — | METSERA INC | $18.4M | 0.31% | 675,525 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $17.2M | 0.29% | 3,181,818 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC-CLASS A | $17.0M | 0.28% | 1,944,247 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $16.9M | 0.28% | 8,340,508 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $16.7M | 0.28% | 848,986 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $16.4M | 0.27% | 14,932,063 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $16.0M | 0.27% | 4,330,446 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $15.8M | 0.26% | 824,582 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $15.8M | 0.26% | 1,333,333 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $15.3M | 0.25% | 200,000 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $15.1M | 0.25% | 10,872,503 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $15.0M | 0.25% | 10,689,545 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $14.7M | 0.25% | 4,563,211 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTIC INC | $14.5M | 0.24% | 3,400,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $13.0M | 0.22% | 6,045,351 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $12.1M | 0.20% | 3,566,338 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $11.9M | 0.20% | 9,695,228 | Common | SOLE |
| 81749D107 | SERA | SERA PROGNOSTICS INC-A | $11.2M | 0.19% | 3,032,808 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $11.2M | 0.19% | 1,511,334 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC-ADR | $9.3M | 0.16% | 1,093,477 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $8.9M | 0.15% | 1,136,364 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $7.9M | 0.13% | 679,130 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $7.9M | 0.13% | 1,750,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $7.7M | 0.13% | 967,000 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAPITAL SOLUTIONS | $7.7M | 0.13% | 750,000 | Common | SOLE |
| 10919W405 | DRUG | Bright Minds Biosciences Inc | $7.4M | 0.12% | 206,427 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $7.1M | 0.12% | 4,666,667 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE CO INC | $6.6M | 0.11% | 217,000 | Common | SOLE |
| 08659B102 | BBNX | BETA BIONICS INC | $6.1M | 0.10% | 500,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $6.1M | 0.10% | 575,000 | Common | SOLE |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $6.0M | 0.10% | 6,144,881 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $5.7M | 0.10% | 7,541,000 | Common | SOLE |
| 44486Q103 | HUMA | HUMACYTE INC | $5.6M | 0.09% | 3,312,356 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $4.2M | 0.07% | 3,217,503 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $4.0M | 0.07% | 1,052,494 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $3.3M | 0.05% | 2,180,631 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA CO NV-27 | $3.0M | 0.05% | 333,333 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $2.9M | 0.05% | 4,434,637 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $1.9M | 0.03% | 546,554 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $635,800 | 0.01% | 1,000,000 | Common | SOLE |
| 80880W106 | SCLXUSD | SCILEX HOLDING CO | $257,500 | 0.00% | 1,036,218 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.